ScholarLens Back to search
2003•Best Practice & Research Clinical Endocrinology & MetabolismRequires access

The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer

Sacha Jon Howell, Stephen R.D. Johnston, Anthony Howell

Open publisher page 160 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 160 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Tamoxifen, Toremifene, Raloxifene, Selective estrogen receptor modulator, Fulvestrant, Antiestrogen, Estrogen receptor, Breast cancer

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer — Research Paper | ScholarLens